6. Jeffrey Leiden, Vertex Pharmaceuticals
2014 Compensation: $36,635,468
Overpaid By: $23,438,711
Since Leiden was named chief executive in February 2012, Vertex’s shares have soared 140 percent. Still, Leiden scored a spot on the list because he was awarded equity grants that were worth more than $10 million and company earnings were low compared to investments, among other red flags cited by As You Sow.
